August 18, 2022

News Science

The Science of News

Hear from first US participant to receive Moderna Phase 3 trial vaccine

1 min read

CNN’s Elizabeth Cohen spoke with Dawn Baker, the first person in the US to get a shot of Moderna’s investigational vaccine in a Phase 3 trial. Moderna is developing it with the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

#CNN #News

News Science © 2005 Area.Control.Network™ All rights reserved.
All Rights Reserved © ACN 2020

ACN Privacy Policies
ACN TOS
Area Control Network (ACN)
Area Control Network
Area Control Network Center